A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN 0402)
Website: https://web.emmes.com/study/bmt2
Parent Study Contact:
Alan Howard,
ahoward@nmdp.org
Study Type:
Clinical Trial
Prepared on May 31, 2012
Consent: Restricted Consent
Consent Restrictions: For protocol use only
Commercial Use Restrictions:
No
Collection Type: Proprietary Study
- See bottom of this webpage for request information
Objectives
The primary objective is to compare the rates of 114-day Grades II-IV acute GVHD free survival between patients in the two study arms from the time of randomization using an intent-to-treat analysis.
Interested parties can contact Alan Howard for further details about specimen availability.